Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
127 studies found for:    "Measles"
Show Display Options
Download search resultsDownload the search results for:
"Measles" (127 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed A Measles, Mumps, and Rubella Investigational Vaccine Trial (V205C-010)(COMPLETED)
Condition: Measles
Interventions: Biological: V205C, measles, mumps, and rubella virus vaccine live;   Biological: Comparator: Measles, Mumps, and Rubella Virus Vaccine Live
2 Not yet recruiting mHealth to Increase Measles Immunization - a Randomized Controlled Trial in Guinea-Bissau
Condition: Measles
Interventions: Other: SMS reminder message;   Other: Voice call + SMS message
3 Active, not recruiting MMR and MMRV Vaccines: Effect of Age at First Dose on Safety and Immunogenicity of the Measles Component.
Condition: Measles
Intervention: Biological: MMR vaccine / MMRV vaccine
4 Unknown  Immunity to Measles Virus in the Thai Population Age 18-30 Years and Predictive Factors
Condition: Measles
Intervention:
5 Completed Early Two-dose Measles Vaccination Trial
Condition: Measles
Intervention: Biological: Measles vaccine
6 Completed Study to Evaluate Safety, Dose Response and Immunogenicity of the Measles Vaccine MVA mBN85B in Healthy Children Aged 6 Months to 6 Years
Condition: Measles
Interventions: Biological: MVA-mBN85B;   Biological: Rouvax
7 Completed Long-term Follow-up of Measles Antibodies
Condition: Measles
Intervention: Biological: Measles vaccine
8 Unknown  Trial of Additional Measles Vaccine to Reduce Child Mortality
Condition: Measles Vaccine
Intervention: Biological: Early measles vaccine
9 Completed Non-Specific Effects of Standard Titre Measles Vaccination
Condition: Measles
Intervention: Biological: Measles and inactivated polio vaccine
10 Unknown  Trial of Additional Measles Vaccine to Reduce Child Mortality. Burkina Faso.
Condition: Measles Vaccine
Intervention: Biological: Early measles vaccine
11 Recruiting Induction of Immunity Against Measles in Pediatric Liver Transplant Recipients
Condition: Measles
Intervention: Biological: MMR vaccination
12 Unknown  Ontogeny of Measles Immunity in Infants
Condition: Measles
Interventions: Biological: Attenuvax (Measles Virus Live Vaccine, 0.5ml subcutaneous);   Biological: MMR-II (Measles-Mumps-Rubella Virus Live Vaccine, 0.5ml subcutaneous)
13 Completed Immune Reconstitution to Measles Virus of HIV Infected Children in Zambia
Condition: Measles
Intervention: Drug: Measles vaccine
14 Unknown  Additional Measles Vaccine at 4 Months of Age
Condition: Measles Infection
Intervention: Biological: Measles vaccine
15 Not yet recruiting Mobile and Scalable Innovations for Measles Immunization: a Randomized Controlled Trial
Condition: Measles
Interventions: Behavioral: SMS reminder;   Behavioral: Unconditional Incentive
16 Unknown  Early Waning of Maternal Measles and Meningitis C Antibodies
Condition: Measles
Intervention:
17 Completed Prophylactic Antibiotics in Measles
Conditions: Post-Measles Pneumonia;   Measles
Intervention: Drug: Sulfamethoxazole-Trimethoprim
18 Completed Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Specified Drug-use Survey of Vaccinees After the Second Vaccination
Condition: Measles/Rubella
Intervention: Drug: Freeze-dried live attenuated measles and rubella combined vaccine (Schwarz FF-8 strain/TO-336 strain)
19 Completed Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Special Drug Use Surveillance of Vaccinees After the First Vaccination
Condition: Measles/Rubella
Intervention: Drug: Freeze-dried live attenuated measles and rubella combined vaccine (Schwarz FF-8 strain/TO-336 strain)
20 Completed
Has Results
A Clinical Trial to Assess the Safety of a Measles Vaccine (Dry Powder) Administered by Two Different Devices
Condition: Prophylaxis for the Measles Infection
Interventions: Biological: PMV via Puffhaler® device;   Biological: PMV via SoloventTM device;   Biological: Licensed Subcutaneous Measles Vaccine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.